Skip to main content
SpringerLink
Log in

Adverse Drug Reaction (ADR) Related to Sertraline in a Breastfeeding Infant through Maternal Exposure: Case Report

  • Abstracts
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wisner KL, Perel JM, Findling RL. Antidepressant Treatment During Breast-Feeding. American Journal of Psychiatry 1996 September; 153(9):1132–7, 1200-5

    PubMed  CAS  Google Scholar 

  2. Ito S, et al. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Amer J Obstet Gynecol 1993; 168: 1383–9

    Google Scholar 

  3. Bennett PN. Br J Clin Pharmacol; 42: p673-4 832-40

  4. Anderson P. Adverse drug reactions in breast-fed infants: less than imagined. Clin Paed 2003; 42: 325–40

    Article  Google Scholar 

  5. Epperson N, Czarkowski KA, Ward-O’Brien D, et al. Maternal Sertraline Treatment and Serotonin Transport in Breast-Feeding Mother-Infant Pairs. American Journal of Psychiatry 2001 Oct; Volume 158(10): pp 1631–7

    Article  PubMed  CAS  Google Scholar 

  6. Stowe ZN, Owens MJ, Landry JC, et al. Sertralinee and Desmethylsertralinee in Human Breast Milk and Nursing Infants. American Journal of Psychiatry 1997 Sep; 154(9):1255–60

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinica Davila, Chile

    M. Morales Díaz

  2. Instituto de Salud Publica de Chile, Chile

    M. Morales Díaz

Authors
  1. M. Morales Díaz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morales Díaz, M. Adverse Drug Reaction (ADR) Related to Sertraline in a Breastfeeding Infant through Maternal Exposure: Case Report. Drug-Safety 31, 885 (2008). https://doi.org/10.2165/00002018-200831100-00176

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200831100-00176

Keywords

Search

Navigation